In an in vivo model of stroke, pharmacological inhibition of PANX1 channels with the clinically used uricosuric drug probenecid decreased infarct size and reduced inflammatory cell recruitment (Freitas-Andrade, et al. 2017). The gene discussed is PANX1; the disease is stroke disorder.